Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy for High Risk Transitional Cell Carcinoma of the Urothelium
NCT00028860Phase 2Completed
- Sponsor
- Tulane University
- Start
- Oct 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, carboplatin, gemcitabine in transitional cell carcinoma of the urothelium (TCC), sponsored by Tulane University. Started Oct 2001; status: completed.
02
Drugs
paclitaxelifosfamidecarboplatingemcitabine
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT00028860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028860.